Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 85

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 85
---
 become more variable. 51 The actual probability of success our Product Candidates or any future product candidate may be affected by a variety of factors, including the safety and efficacy of our product candidates, investment in our clinical programs, manufacturing capability and competition with other products. As a result, we are unable to determine the timing of initiation, duration and completion costs of our research and development efforts or when and to what extent we will generate revenue from the commercialization and sale of our Product Candidates or any future product candidate. General and Administrative Our general and administrative expenses consist primarily of personnel costs, expenses for outside professional services, including financial advisory, legal, human resource, audit and accounting services and consulting costs. Personnel and related costs consist of salaries, employee benefits and stock-based compensation for personnel involved in executive, finance and other administrative functions. We expect our general and administrative expenses to increase for the foreseeable future as we increase the size of our administrative function to support the growth of our business and support our continued research and development activities. We also anticipate increased expenses as we continue to operate as a public company, including increased expenses related to financial advisory services, audit, legal, regulatory, investor relations costs, director and officer insurance premiums associated with maintaining compliance with exchange listing and SEC requirements. Other (Expense) Income, Net Other (expense) income, net primarily consists of the change in fair value of warrant liability, LifeSci Capital LLC judgment expense and reimbursement of legal costs, clinical trial related settlement expenses with A-IR Clinical Research Ltd., foreign currency transaction gains and losses, interest expense and interest income from our cash balances in savings accounts. Results of Operations The following table summarizes our results of operations for the periods presented:

|                                   |     | 2025 |        Three 
       Months 
 Ended March, |   |     | 2024 |            |   |     | Change |          |   |     | 2024 |   Year Ended 
 December 31, |   |     | 2023 |            |   |     | Change |             |   |
|:----------------------------------|:----|:-----|-------------:|:--|:----|:-----|-----------:|:--|:----|:-------|---------:|:--|:----|:-----|-------------:|:--|:----|:-----|-----------:|:--|:----|:-------|------------:|:--|
| Operating expenses:               |     |      |              |   |     |      |            |